CONMED Corporation (CNMD)

Operating profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Operating income US$ in thousands 200,326 120,603 70,054 109,717 46,010
Revenue US$ in thousands 1,307,020 1,244,740 1,045,470 1,010,640 862,459
Operating profit margin 15.33% 9.69% 6.70% 10.86% 5.33%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $200,326K ÷ $1,307,020K
= 15.33%

CONMED Corporation's operating profit margin has shown a steady improvement over the years, reflecting enhanced operational efficiency and profitability. Starting at -3.13% on December 31, 2020, the margin has steadily increased to 3.74% by December 31, 2021, and continued to rise to 6.70% by December 31, 2022. The most significant improvement was seen by December 31, 2023, where the operating profit margin reached 10.51%, indicating a substantial boost in the company's ability to generate profits from its core operations. By December 31, 2024, the margin further improved to 15.33%, showcasing a robust performance in managing operating costs and driving revenue growth. Overall, the positive trajectory of CONMED Corporation's operating profit margin demonstrates its effective management strategies and improving financial health.


Peer comparison

Dec 31, 2024

Company name
Symbol
Operating profit margin
CONMED Corporation
CNMD
15.33%
Abbott Laboratories
ABT
16.27%
Stryker Corporation
SYK
22.40%